Nuveen Asset Management LLC Reduces Stock Position in Quantum-Si incorporated (NASDAQ:QSI)

Nuveen Asset Management LLC cut its holdings in Quantum-Si incorporated (NASDAQ:QSI - Free Report) by 43.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 319,100 shares of the company's stock after selling 245,980 shares during the period. Nuveen Asset Management LLC owned 0.22% of Quantum-Si worth $862,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in QSI. Rhumbline Advisers grew its holdings in Quantum-Si by 3.7% in the fourth quarter. Rhumbline Advisers now owns 148,946 shares of the company's stock valued at $402,000 after purchasing an additional 5,298 shares during the period. SG Americas Securities LLC boosted its holdings in shares of Quantum-Si by 12.4% in the 4th quarter. SG Americas Securities LLC now owns 67,588 shares of the company's stock valued at $182,000 after purchasing an additional 7,470 shares during the last quarter. Mariner LLC grew its stake in shares of Quantum-Si by 29.1% during the 4th quarter. Mariner LLC now owns 33,439 shares of the company's stock valued at $90,000 after buying an additional 7,540 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd increased its holdings in shares of Quantum-Si by 29.4% during the 4th quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 33,902 shares of the company's stock worth $92,000 after buying an additional 7,704 shares during the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Quantum-Si by 13.9% during the 4th quarter. Wells Fargo & Company MN now owns 71,980 shares of the company's stock worth $194,000 after buying an additional 8,802 shares during the last quarter. Hedge funds and other institutional investors own 39.90% of the company's stock.

Insiders Place Their Bets

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the business's stock in a transaction on Friday, March 21st. The shares were sold at an average price of $1.39, for a total value of $32,952.73. Following the transaction, the chief executive officer now owns 2,646,716 shares in the company, valued at $3,678,935.24. The trade was a 0.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders sold a total of 36,650 shares of company stock worth $50,944 in the last 90 days. 30.04% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. HC Wainwright reiterated a "buy" rating and issued a $5.50 target price on shares of Quantum-Si in a report on Monday, May 19th. National Bankshares set a $3.65 price objective on Quantum-Si in a report on Wednesday, March 5th. Finally, Alliance Global Partners reiterated a "buy" rating on shares of Quantum-Si in a report on Friday, May 16th.

Quantum-Si Stock Up 8.7%

Shares of QSI stock traded up $0.14 during mid-day trading on Friday, reaching $1.74. The company's stock had a trading volume of 5,635,300 shares, compared to its average volume of 10,693,953. The firm has a market capitalization of $319.29 million, a PE ratio of -2.72 and a beta of 2.87. The company's 50 day simple moving average is $1.37 and its 200-day simple moving average is $1.67. Quantum-Si incorporated has a 12-month low of $0.61 and a 12-month high of $5.77.

Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings data on Thursday, May 15th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.06. Quantum-Si had a negative return on equity of 36.96% and a negative net margin of 3,968.84%. The company had revenue of $0.84 million for the quarter, compared to analysts' expectations of $0.96 million. As a group, research analysts anticipate that Quantum-Si incorporated will post -0.65 EPS for the current fiscal year.

Quantum-Si Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.